Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
QuintilesIMS
Harvard Business School
Boehringer Ingelheim
Covington
Cerilliant
Healthtrust
Daiichi Sankyo
McKesson

Generated: February 23, 2018

DrugPatentWatch Database Preview

PROMETHAZINE VC W/ CODEINE Drug Profile

« Back to Dashboard

When do Promethazine Vc W/ Codeine patents expire, and when can generic versions of Promethazine Vc W/ Codeine launch?

Promethazine Vc W/ Codeine is a drug marketed by Cenci and Wockhardt and is included in two NDAs.

The generic ingredient in PROMETHAZINE VC W/ CODEINE is codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride. There are nineteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride profile page.

US Patents and Regulatory Information for PROMETHAZINE VC W/ CODEINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cenci PROMETHAZINE VC W/ CODEINE codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride SYRUP;ORAL 088816-001 Nov 22, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wockhardt PROMETHAZINE VC W/ CODEINE codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride SYRUP;ORAL 088896-001 Jan 4, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
US Department of Justice
AstraZeneca
Dow
Boehringer Ingelheim
Johnson and Johnson
Queensland Health
Colorcon
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot